Skip to main content

Public demand for AstraZeneca vaccine falls in Britain after blood clot scares

Public preference for the AstraZeneca vaccine has fallen since reports potentially linking it to some cases of unusual blood clotting cases, a U.K. study shows.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.